Activation of adenylate cyclase and inhibition of glucose transport in rat adipocytes by forskolin analogues: structural determinants for distinct sites of action.

Forskolin and four analogues of forskolin, 7-beta-[gamma-(N'-methylpiperazino)-butyryloxy]-7-desacet ylforskolin, 7-desacetylforskolin, 7-tosyl-7-desacetylforskolin, and 1,9-dideoxyforskolin, were tested for their ability to activate adenylate cyclase, inhibit glucose transport, and inhibit cytochalasin B binding in rat adipocyte membranes. Forskolin was the most potent analogue in activating adenylate cyclase with an EC50 of 2 microM, whereas 7-beta-[gamma-(N'-methylpiperazino)butyryloxy]-7-desacety lforskolin and 7-desacetylforskolin were less potent, with EC50 values of 3 microM and 20 microM, respectively. The 7-tosyl-7-desacetylforskolin and 1,9-dideoxyforskolin did not stimulate adenylate cyclase even at the highest concentrations tested (100 microM). In contrast, forskolin and all of the analogues were able to fully inhibit glucose transport in adipocyte plasma membranes. The order of potency for the inhibition was forskolin greater than 7-beta-[gamma-(N'-methylpiperazino)butyryloxy]-7-desacety lforskolin greater than 7-desacetylforskolin greater than 7-tosyl-7-desacetylforskolin greater than 1,9-dideoxyforskolin, and the EC50 values were 0.24 microM, 1.8 microM, 7.1 microM, 8.8 microM, and 12.8 microM, respectively. Cytochalasin B binding to rat adipocyte membranes was inhibited by forskolin and the four analogues with the same order of potency as observed for the inhibition of glucose transport. Thus, the site of action of forskolin which is responsible for the inhibition of glucose transport and cytochasin B binding exhibits structural requirements for forskolin and its analogues that are different from those of the site responsible for the activation of adenylate cyclase.

• Publication year

  1988

• Venue

  Molecular Pharmacology

• Publication date

  1988-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/s0026-895x(25)13328-2PMID 3357486
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Stimulation of adenylate cyclase by water-soluble analogues of forskolin.

  1987cited by this paper
• [3H]forskolin. Direct photoaffinity labeling of the erythrocyte D-glucose transporter.

  1987cited by this paper
• Forskolin inhibits insulin-stimulated glucose transport in rat adipose cells by a direct interaction with the glucose transporter.

  1987cited by this paper
• Insulin-stimulated glucose transport in rat adipose cells. Modulation of transporter intrinsic activity by isoproterenol and adenosine.

  1986cited by this paper
• Binding of [3H]forskolin to human platelet membranes. Regulation by guanyl-5'-yl imidodiphosphate, NaF, and prostaglandins E1 and D2.

  1986cited by this paper
• Glucose transport in human platelets and its inhibition by forskolin.

  1986cited by this paper
• Direct anesthetic-like effects of forskolin on the nicotinic acetylcholine receptors of PC12 cells.

  1986cited by this paper
• Forskolin: its biological and chemical properties.

  1986cited by this paper
• Inhibition of 3-O-methylglucose transport in human erythrocytes by forskolin.

  1985cited by this paper
• Characterization of a photosensitive glucose derivative. A photoaffinity reagent for the erythrocyte hexose transporter.

  1985cited by this paper
• Binding of [3H]forskolin to rat brain membranes.

  1984cited by this paper
• The regulation of glucose transport by cAMP stimulators via three different mechanisms in rat and human adipocytes.

  1983cited by this paper
• Structure-activity relationships for activation of adenylate cyclase by the diterpene forskolin and its derivatives.

  1983cited by this paper
• Insulin-stimulated translocation of glucose transporters in the isolated rat adipose cells: characterization of subcellular fractions.

  1983cited by this paper
• The antihypertensive and positive inotropic diterpene forskolin: effects of structural modifications on its activity.

  1983cited by this paper
• Stimulation of forskolin of intact S49 lymphoma cells involves the nucleotide regulatory protein of adenylate cyclase.

  1982cited by this paper
• Direct evidence for the role of the coupling proteins in forskolin activation of adenylate cyclase.

  1982cited by this paper
• Hydrogen bonding requirements for the insulin-sensitive sugar transport system of rat adipocytes.

  1981cited by this paper
• Potential mechanism of insulin action on glucose transport in the isolated rat adipose cell. Apparent translocation of intracellular transport systems to the plasma membrane.

  1980cited by this paper
• Cytochalasin B and the kinetics of inhibition of biological transport: a case of asymmetric binding to the glucose carrier.

  1978cited by this paper
• A highly sensitive adenylate cyclase assay.

  1974cited by this paper
• Structural requirements of D-glucose for its binding to isolated human erythrocyte membranes.

  1972cited by this paper

• Retinal metabolism displays evidence for uncoupling of glycolysis and oxidative phosphorylation via Cori-, Cahill-, and mini-Krebs-cycle

  2024cites this paper
• Retinal energy metabolism: Photoreceptors switch between Cori, Cahill, and mini-Krebs 1 cycles to uncouple glycolysis from mitochondrial respiration

  2022cites this paper
• (+)-Larixol and Larixyl Acetate: Syntheses, Phytochemical Studies and Biological Activity Assessments

  2021cites this paper
• International Union of Basic and Clinical Pharmacology. CI. Structures and Small Molecule Modulators of Mammalian Adenylyl Cyclases

  2017cites this paper
• DEVELOPMENT OF PHARMACOLOGICAL TOOLS FOR THE IDENTIFICATION OF G PROTEIN-COUPLED RECEPTORS LIGANDS

  2016cites this paper
• Could changes in adiponectin drive the effect of statins on the risk of new-onset diabetes? The case of pitavastatin.

  2015cites this paper
• Catecholamine-induced lipolysis causes mTOR complex dissociation and inhibits glucose uptake in adipocytes

  2014cites this paper
• On the High value Medicinal plant, Coleus forskohlii Briq.

  2013cites this paper
• Suppression of GLUT1; A new strategy to prevent diabetic complications

  2013cites this paper
• The role of adipocyte CREB in insulin resistance

  2011cites this paper
• Plectranthus barbatus: A Review of Phytochemistry, Ethnobotanical Uses and Pharmacology – Part 2

  2010cites this paper
• Defining topological features of membrane proteins by nanoelectrospray ionisation mass spectrometry.

  2010cites this paper
• cAMP Signalling in Modification of DNA Damage Responses in Lymphoid Cells : Implications for Development and Treatment of BCP-ALL

  2010cites this paper
• Concomitant activation of adenylyl cyclase suppresses the opposite influences of CB(1) cannabinoid receptor agonists on tyrosine hydroxylase expression.

  2009cites this paper
• Adipocyte CREB promotes insulin resistance in obesity.

  2009cites this paper
• Cell Metabolism Role of CREB in Obesity active

  2009cites this paper
• Transcriptional and post-translational regulation of adiponectin.

  2009cites this paper
• Cholecystokinin-2 receptors couple to cAMP-protein kinase A to depress excitatory synaptic currents in rat nucleus accumbens in vitro.

  2006cites this paper
• Synthetic transformation of ptychantin into forskolin and 1,9-dideoxyforskolin.

  2006cites this paper
• Cholecystokinin inhibits evoked inhibitory postsynaptic currents in the rat nucleus accumbens indirectly through γ‐aminobutyric acid and γ‐aminobutyric acid type B receptors

  2005cites this paper
• Cholecystokinin inhibits evoked inhibitory postsynaptic currents in the rat nucleus accumbens indirectly through gamma-aminobutyric acid and gamma-aminobutyric acid type B receptors.

  2005cites this paper
• Differential functional effects of two 5-HT4 receptor isoforms in adult cardiomyocytes.

  2005cites this paper
• Predicting the three-dimensional structure of the human facilitative glucose transporter glut1 by a novel evolutionary homology strategy: insights on the molecular mechanism of substrate migration, and binding sites for glucose and inhibitory molecules.

  2004cites this paper
• Dissection of discrete kinetic events in the binding of antibiotics and substrates to the galactose-H+ symport protein, GalP, ofEscherichia coli

  2004cites this paper
• First synthesis of 1,9-dideoxyforskolin from ptychantin A

  2003cites this paper
• Central galanin administration blocks consolidation of spatial learning.

  2003cites this paper
• Potentiation of glycine responses by dideoxyforskolin and tamoxifen in rat spinal neurons

  2003cites this paper
• The adenylate cyclase activator forskolin partially protects L929 cells against tumour necrosis factor-alpha-mediated cytotoxicity via a cAMP-independent mechanism.

  2002cites this paper
• Synthesis of B-ring functionalised intermediates for the preparation of 1,9-dideoxy-forskolin derivatives

  2001cites this paper
• Regulation of steroidogenic enzymes and a novel testicular RNA helicase.

  2001cites this paper
• Cysteine residues in the D-galactose-H+ symport protein of Escherichia coli: effects of mutagenesis on transport, reaction with N-ethylmaleimide and antibiotic binding.

  2001cites this paper
• Phosphodiesterase inhibitors and forskolin Up-regulate arginase activity in rabbit alveolar macrophages.

  2000cites this paper
• On the analogy between forskolin and D-glucose.

  1999cites this paper
• Forskolin inhibits 5-hydroxytryptamine-induced phosphoinositide hydrolysis and Ca+2 Mobilisation in canine cultured aorta smooth muscle cells.

  1999cites this paper
• Effect of forskolin on endothelin-induced phosphoinositide hydrolysis and calcium mobilization in cultured canine tracheal smooth muscle cells.

  1998cites this paper
• Essential Role of Adenosine Triphosphate in Activation of 17β-Hydroxysteroid Dehydrogenase in the Rat Leydig Cell.

  1997influential citation
• Some cyclic nucleotides reduce phenylephrine-induced and phorbol ester-induced constriction of the rat anterior mesenteric artery.

  1997cites this paper
• Separation of forskolin derivatives by automated multiple development high-performance thin-layer chromatography

  1997cites this paper
• Effect of forskolin on bradykinin-induced calcium mobilization in cultured canine tracheal smooth muscle cells.

  1997cites this paper
• Effects of CAMP elevating agents on carbachol-induced phosphoinositide hydrolysis and calcium mobilization in cultured canine tracheal smooth muscle cells

  1996cites this paper
• Regulation of 5-hydroxytryptamine-induced calcium mobilization by cAMP-elevating agents in cultured canine tracheal smooth muscle cells

  1996cites this paper
• Effect of cAMP elevating agents on carbachol-induced phosphoinositide hydrolysis and calcium mobilization in cultured canine tracheal smooth muscle cells.

  1996cites this paper
• Complexity and diversity of mammalian adenylyl cyclases.

  1996cites this paper
• Long‐Term Effect of Forskolin on the Activation of Adenylyl Cyclase in Astrocytes

  1996cites this paper
• Forskolin-mediated induction of CYP3A1 mRNA expression in primary rat hepatocytes is independent of elevated intracellular cyclic AMP.

  1996cites this paper
• Cyclic AMP-independent inhibition of cardiac calcium current by forskolin.

  1996cites this paper
• Cyclic AMP‐Independent Inhibition of Voltage‐Sensitive Calcium Channels by Forskolin in PC12 Cells

  1996cites this paper
• Substrate specificity and kinetic parameters of GLUT3 in rat cerebellar granule neurons.

  1996cites this paper
• The preparation of forskolin analogs via quinone Diels-Alder reactions

  1996cites this paper
• Construction of a soluble adenylyl cyclase activated by Gs alpha and forskolin.

  1995cites this paper
• Plant hallucinogens: springboards for psychotherapeutic drug discovery.

  1995cites this paper
• Vasopressin-stimulated Electrogenic Sodium Transport in A6 Cells Is Linked to a Ca2+-mobilizing Signal Mechanism (*)

  1995cites this paper
• Kinetics and thermodynamics of the binding of forskolin to the galactose-H+ transport protein, GalP, of Escherichia coli.

  1995cites this paper
• Forskolin specifically inhibits the bacterial galactose-H+ transport protein, GalP.

  1994cites this paper
• 31P NMR investigation of energy metabolism in perifused MMQ cells

  1994cites this paper
• Antagonism by forskolin of the 5-HT3 receptor-mediated current in nodose ganglion neurons is independent of cyclic AMP.

  1994cites this paper
• The interaction of forskolin with the galactose-H+ transport protein (GalP) of Escherichia coli.

  1994cites this paper
• Localization of the forskolin labeling sites to both halves of P-glycoprotein: similarity of the sites labeled by forskolin and prazosin.

  1994cites this paper
• Stimulation of Na+,K+,Cl- cotransport by forskolin-activated adenylyl cyclase in fetal human nonpigmented epithelial cells.

  1994cites this paper
• Intercellular gap formation induced by thrombin in confluent cultured bovine retinal pigment epithelial cells.

  1994cites this paper
• Forskolin and congeners.

  1994cites this paper
• Phorbol ester stimulation of the type I and type III adenylyl cyclases in whole cells.

  1993cites this paper
• Interaction of 7-bromoacetyl-7-desacetylforskolin, and alkylating derivative of forskolin, with bovine brain adenylyl cyclase and human erythrocyte glucose transporter.

  1993cites this paper
• Mouse hypothalamic growth hormone-releasing hormone and somatostatin responses to probes of signal transduction systems.

  1993cites this paper
• Beta 3-adrenergic receptors are responsible for the adrenergic inhibition of insulin-stimulated glucose transport in rat adipocytes.

  1993cites this paper
• Mammalian passive glucose transporters: members of an ubiquitous family of active and passive transport proteins.

  1993cites this paper
• Characterization of [3H]forskolin binding sites in the human caudate nucleus.

  1993cites this paper
• Carbon-11-forskolin: a ligand for visualization of the adenylate cyclase-related second messenger system.

  1993cites this paper
• In vitro modulation of cisplatin accumulation in human ovarian carcinoma cells by pharmacologic alteration of microtubules.

  1993cites this paper
• The transduction system in the isoproterenol activation of the Ca(2+)- activated K+ channel in guinea pig taenia coli myocytes

  1993cites this paper
• Cyclic AMP‐induced inhibition of collagen lattice contraction by fibroblasts may be attenuated by both cyclic AMP dependent and independent mechanisms

  1993cites this paper
• Glucose transport activity and photolabelling with 3-[125I]iodo-4-azidophenethylamido-7-O-succinyldeacetyl (IAPS)-forskolin of two mutants at tryptophan-388 and -412 of the glucose transporter GLUT1: dissociation of the binding domains of forskolin and glucose.

  1993cites this paper
• Localization of the binding domain of the inhibitory ligand forskolin in the glucose transporter GLUT-4 by photolabeling, proteolytic cleavage and a site-specific antiserum.

  1992cites this paper
• Cyclic AMP modulation of human B cell proliferative responses: role of cAMP-dependent protein kinases in enhancing B cell responses to phorbol diesters and ionomycin.

  1992cites this paper
• Pharmacology of second messengers: a critical appraisal.

  1992cites this paper
• Chapter 6 Mechanisms of active and passive transport in a family of homologous sugar transporters found in both prokaryotes and eukaryotes

  1992cites this paper
• Inhibition of 25-hydroxyvitamin D3-24-hydroxylase by forskolin: evidence for a 3',5'-cyclic adenosine monophosphate-independent mechanism.

  1992cites this paper
• Interaction of aminoalkylcarbamates of forskolin with adenylyl cyclase: synthesis of an iodinated derivative of forskolin with high affinity for adenylyl cyclase.

  1992cites this paper
• Cholera and pertussis toxins modify regulation of glucose transport activity in rat adipose cells: evidence for mediation of a cAMP-independent process by G-proteins.

  1992cites this paper
• Determination of levels of cyclic AMP in the myenteric plexus of guinea-pig small intestine.

  1991cites this paper
• (Aminoalkyl)carbamates of forskolin: intermediates for the synthesis of functionalized derivatives of forskolin with different specificities for adenylyl cyclase and the glucose transporter.

  1991cites this paper
• Interaction of forskolin with the P-glycoprotein multidrug transporter.

  1991cites this paper
• Forskolin photoaffinity labels with specificity for adenylyl cyclase and the glucose transporter.

  1991cites this paper
• Differentiation of erythrocyte-(GLUT1), liver-(GLUT2), and adipocyte-type (GLUT4) glucose transporters by binding of the inhibitory ligands cytochalasin B, forskolin, dipyridamole, and isobutylmethylxanthine.

  1991cites this paper
• Beta-adrenergic-cyclic AMP signalling pathway modulates cell function at the transcriptional level in 3T3-F442A adipocytes.

  1991cites this paper
• High-affinity binding sites for [3H]forskolin.

  1991cites this paper
• Modulation of cis‐diamminedichloroplatinum(II) accumulation and sensitivity by forskolin and 3‐isobutyl‐1‐methylxanthine in sensitive and resistant human ovarian carcinoma cells

  1991cites this paper
• Mitogenic response of rat schwann cells to fibroblast growth factors is potentiated by increased intracellular cyclic AMP levels

  1991cites this paper
• Alteration of the functional activity of Gs protein in thyrotropin-desensitized pig thyroid cells.

  1991cites this paper
• Type 1 and 2 isoenzymes of cAMP-dependent protein kinase in Leydig cell steroidogenesis.

  1991cites this paper
• Search for New Drugs of Plant Origin

  1991cites this paper
• High affinity forskolin inhibition of L-type Ca2+ current in cardiac cells.

  1990cites this paper
• cAMP-independent effects of cholera toxin on B cell activation. I. A possible role for cell surface ganglioside GM1 in B cell activation.

  1990cites this paper
• Platelet-derived growth factors and fibroblast growth factors are mitogens for rat Schwann cells

  1990cites this paper
• Modulation of calcium‐activated non‐specific cation currents by cyclic AMP‐dependent phosphorylation in neurones of Helix.

  1990cites this paper
• Localization of the forskolin photolabelling site within the monosaccharide transporter of human erythrocytes.

  1990cites this paper
• Platelet-derived Growth Factors and Fibroblast Growth Factors Are Mitogens for Rat Schwalm Cells

  1990cites this paper
• Amplification of cyclic AMP generation reveals agonistic effects of certain beta-adrenergic antagonists.

  1990cites this paper
• Irreversible loss of [3H]forskolin binding sites in human platelets by alpha-haloacetyl analogs of forskolin.

  1990cites this paper
• Forskolin: a specific stimulator of adenylyl cyclase or a diterpene with multiple sites of action?

  1989cites this paper